Dulaglutide (Trulicity) Explained: A Weekly GLP-1 With a Cardiovascular Outcomes Story
If you are reading about Trulicity because someone in your life takes it for weight loss, the first thing worth knowing is that dulaglutide does not have an FDA-approved weight-management indication. It never has. The confusion is understandable — Trulicity belongs to the same GLP-1 receptor agonist drug class as Ozempic and Wegovy, and the […]
Dulaglutide (Trulicity) Explained: A Weekly GLP-1 With a Cardiovascular Outcomes Story Read More »









